Skip to main content
In stock|Targeted Therapy

Selinexor

Oncology TypeHematologic (Multiple Myeloma/DLBCL)
Drug Class / MechanismXPO1 (Exportin-1) Inhibitor
No Image
Description

Selinexor is classified as a XPO1 (Exportin-1) Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic (Multiple Myeloma/DLBCL)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3